TipRanks
Spire Healthcare Group PLC (GB:SPI)
LSE:SPI
UK Market
SPI
Spire Healthcare
RESEARCH TOOLSreports
Want to see GB:SPI full AI Analyst Report?

Spire Healthcare (SPI) Ratios

71 Followers

Spire Healthcare Ratios

GB:SPI's free cash flow for Q2 2026 was £0.37. For the 2026 fiscal year, GB:SPI's free cash flow was decreased by £ and operating cash flow was £0.06. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 0.58 0.63 0.66 0.69 0.77
Quick Ratio
 0.46 0.49 0.52 0.56 0.63
Cash Ratio
 0.08 0.10 0.12 0.16 0.26
Solvency Ratio
 0.07 0.08 0.09 0.08 0.07
Operating Cash Flow Ratio
 0.62 0.63 0.69 0.63 0.57
Short-Term Operating Cash Flow Coverage
 1.98 1.98 65.47 58.79 55.34
Net Current Asset Value
£ -1.42B£ -1.42B£ -1.37B£ -1.33B£ -1.22B
Leverage Ratios
Debt-to-Assets Ratio
 0.56 0.55 0.55 0.55 0.55
Debt-to-Equity Ratio
 1.80 1.77 1.71 1.70 1.63
Debt-to-Capital Ratio
 0.64 0.64 0.63 0.63 0.62
Long-Term Debt-to-Capital Ratio
 0.33 0.33 0.33 0.33 0.31
Financial Leverage Ratio
 3.24 3.20 3.13 3.09 2.95
Debt Service Coverage Ratio
 1.14 1.23 2.33 2.33 2.09
Interest Coverage Ratio
 1.11 1.39 1.40 1.36 1.14
Debt to Market Cap
 0.48 0.71 0.40 0.40 0.35
Interest Debt Per Share
 3.52 3.55 3.42 3.34 3.18
Net Debt to EBITDA
 5.30 4.82 4.95 5.22 5.78
Profitability Margins
Gross Profit Margin
37.53%37.92%45.24%38.31%36.75%
EBIT Margin
7.46%9.25%9.15%9.39%7.96%
EBITDA Margin
15.31%16.82%16.57%17.01%16.13%
Operating Profit Margin
7.46%9.25%9.10%9.31%8.69%
Pretax Profit Margin
-0.44%1.18%2.53%2.55%0.33%
Net Profit Margin
-0.12%1.04%1.68%2.01%0.72%
Continuous Operations Profit Margin
-0.08%1.09%1.72%2.05%0.68%
Net Income Per EBT
27.14%88.17%66.32%78.90%220.51%
EBT Per EBIT
-5.96%12.73%27.85%27.35%3.74%
Return on Assets (ROA)
-0.08%0.69%1.08%1.19%0.40%
Return on Equity (ROE)
-0.26%2.21%3.39%3.69%1.18%
Return on Capital Employed (ROCE)
5.87%7.20%6.87%6.42%5.55%
Return on Invested Capital (ROIC)
1.03%6.31%4.43%4.92%5.28%
Return on Tangible Assets
-0.10%0.85%1.33%1.48%0.59%
Earnings Yield
-0.19%2.45%2.79%3.01%0.94%
Efficiency Ratios
Receivables Turnover
 15.82 14.63 14.35 13.63 14.13
Payables Turnover
 12.75 11.39 9.75 13.12 11.28
Inventory Turnover
 22.17 21.23 17.76 18.93 18.67
Fixed Asset Turnover
 0.94 0.93 0.91 0.84 0.76
Asset Turnover
 0.67 0.66 0.64 0.59 0.55
Working Capital Turnover Ratio
 -11.46 -12.86 -14.16 -16.83 -121.06
Cash Conversion Cycle
 10.91 10.10 8.54 18.24 13.02
Days of Sales Outstanding
 23.07 24.95 25.43 26.78 25.83
Days of Inventory Outstanding
 16.46 17.19 20.55 19.29 19.55
Days of Payables Outstanding
 28.62 32.04 37.44 27.82 32.36
Operating Cycle
 39.53 42.15 45.99 46.06 45.38
Cash Flow Ratios
Operating Cash Flow Per Share
 0.54 0.55 0.58 0.50 0.40
Free Cash Flow Per Share
 0.39 0.36 0.31 0.29 0.18
CapEx Per Share
 0.15 0.19 0.28 0.21 0.22
Free Cash Flow to Operating Cash Flow
 0.72 0.65 0.52 0.58 0.45
Dividend Paid and CapEx Coverage Ratio
 3.23 2.56 1.95 2.31 1.83
Capital Expenditure Coverage Ratio
 3.54 2.87 2.10 2.37 1.83
Operating Cash Flow Coverage Ratio
 0.17 0.17 0.18 0.16 0.13
Operating Cash Flow to Sales Ratio
 0.14 0.14 0.16 0.15 0.13
Free Cash Flow Yield
15.77%21.39%13.55%12.72%7.93%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 -525.53 40.73 35.87 33.27 106.76
Price-to-Sales (P/S) Ratio
 0.63 0.42 0.60 0.67 0.77
Price-to-Book (P/B) Ratio
 1.37 0.90 1.22 1.23 1.26
Price-to-Free Cash Flow (P/FCF) Ratio
 6.34 4.68 7.38 7.86 12.61
Price-to-Operating Cash Flow Ratio
 4.56 3.05 3.87 4.54 5.72
Price-to-Earnings Growth (PEG) Ratio
 4.77 -1.17 -5.27 0.15 -0.57
Enterprise Value Multiple
 9.40 7.34 8.59 9.15 10.53
Enterprise Value
 2.27B 1.95B 2.15B 2.12B 2.03B
EV to EBITDA
 9.40 7.34 8.59 9.15 10.53
EV to Sales
 1.44 1.23 1.42 1.56 1.70
EV to Free Cash Flow
 14.53 13.63 17.40 18.32 27.95
EV to Operating Cash Flow
 10.43 8.89 9.12 10.58 12.68
Tangible Book Value Per Share
 0.71 0.75 0.77 0.74 0.08
Shareholders’ Equity Per Share
 1.81 1.86 1.85 1.83 1.82
Tax and Other Ratios
Effective Tax Rate
 0.81 0.08 0.32 0.19 -1.10
Revenue Per Share
 3.93 3.95 3.75 3.37 2.98
Net Income Per Share
 >-0.01 0.04 0.06 0.07 0.02
Tax Burden
 0.27 0.88 0.66 0.79 2.21
Interest Burden
 -0.06 0.13 0.28 0.27 0.04
Research & Development to Revenue
 0.00 0.00 0.00 0.00 0.00
SG&A to Revenue
 0.30 0.29 0.28 0.00 0.00
Stock-Based Compensation to Revenue
 0.00 <0.01 <0.01 <0.01 <0.01
Income Quality
 -114.42 11.79 9.28 7.32 18.66
Currency in GBP